SCHAFFER DAVID
Known title: DirectorCIK: 0001692929
Associated companies
Transaction History
| FDMT | ▼ Sell | Open Market | 1,900 | $59K | 10/22/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 22,820 | $720K | 10/21/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 11,565 | $359K | 10/20/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 7,836 | $209K | 9/30/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 4,549 | $124K | 9/30/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 700 | $21K | 9/29/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 7,806 | $219K | 9/29/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 8,365 | $243K | 9/29/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 100 | $3K | 9/28/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 13,812 | $421K | 9/28/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 100 | $3K | 9/27/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 13,075 | $426K | 9/27/2021 | View on chart |
| FDMT | ▼ Sell | Open Market | 6,157 | $206K | 9/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
FDMT listed in Benzinga pre-market movers
4D Molecular Therapeutics was mentioned in a Benzinga report on stocks moving lower in Friday’s pre-market session. The article grouped FDMT with other companies like Scholastic and Zscaler, noting a generally downbeat tone among legacy education and other large-cap names. This indicates the stock was part of a broader market movement rather than reacting to a company-specific announcement.
FDMT listed in Benzinga pre-market movers. 4D Molecular Therapeutics was mentioned in a Benzinga report on stocks moving lower in Friday’s pre-market session. The article grouped FDMT with other companies like Scholastic and Zscaler, noting a generally downbeat tone among legacy education and other large-cap names. This indicates the stock was part of a broader market movement rather than reacting to a company-specific announcement.